Physician profile
Olivia Levy
NPI 1386356509
$793.40
in general payments reported to CMS, 2019-2025
13 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.31 · 2023: $363 · 2024: $171 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.08 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $255.76 | 2023 | Dermabond |
| Intuitive Surgical, INC. | $124.09 | 2025 | |
| Merck Sharp & Dohme LLC | $119.52 | 2024-2025 | Bridion |
| Medtronic, INC. | $89.99 | 2023 | Intellis Adaptivestim |
| Convatec INC. | $35.18 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $30.61 | 2024 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $29.16 | 2024 | Gattex |
| W. L. Gore & Associates, INC. | $24.75 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Tela Bio, INC. | $18.11 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lilly USA, LLC | $17.26 | 2025 | Mounjaro |
| Axonics, INC. | $17.09 | 2023 | Axonics |
| Masimo Corporation | $16.31 | 2022 | |
| Springworks Therapeutics, INC. | $15.57 | 2024 | Ogsiveo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.